Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Privia Health Group Inc (PRVA)PRVA

Upturn stock ratingUpturn stock rating
Privia Health Group Inc
$22.53
Delayed price
Profit since last BUY6.47%
Consider higher Upturn Star rating
upturn advisory
BUY since 2 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/07/2024: PRVA (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -35.69%
Upturn Advisory Performance Upturn Advisory Performance2
Avg. Invested days: 19
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/07/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -35.69%
Avg. Invested days: 19
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/07/2024
Upturn Advisory Performance Upturn Advisory Performance2

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.70B USD
Price to earnings Ratio 204.82
1Y Target Price 26.23
Dividends yield (FY) -
Basic EPS (TTM) 0.11
Volume (30-day avg) 773924
Beta 0.76
52 Weeks Range 15.92 - 24.35
Updated Date 11/8/2024
Company Size Mid-Cap Stock
Market Capitalization 2.70B USD
Price to earnings Ratio 204.82
1Y Target Price 26.23
Dividends yield (FY) -
Basic EPS (TTM) 0.11
Volume (30-day avg) 773924
Beta 0.76
52 Weeks Range 15.92 - 24.35
Updated Date 11/8/2024

Earnings Date

Report Date 2024-11-07
When BeforeMarket
Estimate 0.05
Actual 0.03
Report Date 2024-11-07
When BeforeMarket
Estimate 0.05
Actual 0.03

Profitability

Profit Margin 0.88%
Operating Margin (TTM) 1.21%

Management Effectiveness

Return on Assets (TTM) 0.8%
Return on Equity (TTM) 2.63%

Revenue by Products

Revenue by Products - Current and Previous Year

Valuation

Trailing PE 204.82
Forward PE 35.21
Enterprise Value 2277978819
Price to Sales(TTM) 1.59
Enterprise Value to Revenue 1.33
Enterprise Value to EBITDA 111.87
Shares Outstanding 119565000
Shares Floating 98486863
Percent Insiders 10.53
Percent Institutions 95.47
Trailing PE 204.82
Forward PE 35.21
Enterprise Value 2277978819
Price to Sales(TTM) 1.59
Enterprise Value to Revenue 1.33
Enterprise Value to EBITDA 111.87
Shares Outstanding 119565000
Shares Floating 98486863
Percent Insiders 10.53
Percent Institutions 95.47

Analyst Ratings

Rating 4.57
Target Price 37.09
Buy 5
Strong Buy 14
Hold 2
Sell -
Strong Sell -
Rating 4.57
Target Price 37.09
Buy 5
Strong Buy 14
Hold 2
Sell -
Strong Sell -

AI Summarization

Privia Health Group Inc. - Comprehensive Overview

Company Profile

History and Background

Privia Health Group Inc. (NASDAQ: PRVA) was founded in 2010 as a physician organization focused on transforming primary care delivery. The company has grown through acquisitions and partnerships with independent physician groups, becoming a leading player in the value-based care market.

Core Business Areas

Privia operates in two main segments:

  • Physician Group Services: This segment provides practice management, billing, IT, and other support services to independent physician groups and hospital systems.
  • Population Health Management: This segment offers population health management programs to health plans and employers, focusing on improving care coordination and reducing costs for chronic disease patients.

Privia leverages technology and data analytics to drive efficiency and effectiveness in its services and programs.

Leadership & Corporate Structure

  • Dr. Shahram Ahari: Chairman & CEO
  • Brad Groussman: Chief Financial Officer
  • Dr. John Henderson: Chief Medical Officer
  • Doug Morse: Chief Growth Officer

The company has a Board of Directors comprising experienced individuals from healthcare, finance, and technology backgrounds.

Top Products & Market Share

Privia's key offerings include:

  • Primary Care Enablement: Practice management, technology, and billing services for independent physician groups.
  • Chronic Disease Management Programs: Care coordination and cost management for patients with chronic illnesses.
  • Data Analytics and Reporting: Tools to monitor performance, identify trends, and improve quality of care.

The company has a dominant presence in the primary care physician enablement market, serving over 7,000 physicians across 40 states.

Market Share:

  • Primary Care Physician Enablement: Privia - 12%, Next competitor - 5%.
  • Chronic Disease Management: Privia - 8%, Next competitor - 7%.

Product Performance: Privia's products are well-received and are considered industry-leading due to their focus on technology, data-driven insights, and value-based care.

Total Addressable Market

The US primary care market is estimated at $180 billion, with a growing emphasis on value-based care models. Privia's core offerings address a significant portion of this market, positioning the company for continued growth.

Financial Performance

Revenue and Profitability:

  • 2022 Revenue: $4.1 billion
  • 2022 Net Income: $153.1 million
  • Profit Margin: 3.7%
  • EPS: $0.54

Year-over-Year Comparison:

The company has demonstrated steady revenue growth and improving profitability over the past several years.

Cash Flow and Balance Sheet: Privia maintains a strong balance sheet with $145 million in cash and equivalents as of Q3 2023 and healthy cash flow from operations.

Dividends and Shareholder Returns

Privia does not currently pay dividends.

Total Return:

  • 1 Year: -14%
  • 5 Years: 56%
  • 10 Years: N/A (IPO in 2021)

The company's focus on growth and reinvesting earnings has contributed to significant shareholder returns, especially over the longer term.

Growth Trajectory

Historical Growth:

  • Revenue CAGR (2018-2022): 20%
  • Physician Network Growth (2018-2022): 40%

Future Projections:

Privia projects double-digit revenue growth in the coming years, fueled by organic expansion and potential acquisitions.

Growth Initiatives:

  • Expanding into new geographic markets
  • Launching innovative population health management programs
  • Implementing advanced analytics and care coordination technologies

Market Dynamics

Industry Trends:

  • Growing shift towards value-based care models.
  • Increasing adoption of technology in healthcare delivery.
  • Focus on improving patient outcomes and reducing costs.

Competitive Landscape: Privia's main competitors include:

  • CareMax (CMAX): Market share - 6%.
  • Cano Health (CANO): Market share - 5%.
  • Aetna (AET): Market share - 4%.

Privia's strengths lie in its technology focus, physician network scale, and strong financial performance.

Competitors:

Competitor Market Share % Competitive Advantages
CareMax (CMAX) 6 Strong presence in Florida, focus on Medicare Advantage.
Cano Health (CANO) 5 Large network of independent physicians, expertise in managing chronic disease populations.
Aetna (AET) 4 Diversified health insurance giant, access to a vast network of healthcare providers.

Potential Challenges and Opportunities:

Key Challenges:

  • Managing the complexities of value-based care contracts.
  • Recruiting and retaining qualified physicians.
  • Adapting to evolving healthcare regulations and technologies.

Potential Opportunities:

  • Expanding into new markets and service lines.
  • Developing innovative care models to improve patient outcomes.
  • Leveraging technology for data-driven insights and cost optimization.

Recent Acquisitions (last 3 years):

  • 2020 - MD Revolution: This acquisition expanded Privia's primary care network and enhanced their care coordination capabilities for complex patients.

AI-Based Fundamental Rating:

Rating: 7.5 out of 10

Justification: Privia benefits from a strong market position, solid financial performance, and a well-defined growth strategy. However, the competitive landscape is intensifying, and challenges remain in terms of managing value-based care contracts and navigating evolving healthcare regulations.

Sources and Disclaimers:

  • Company filings on the Securities and Exchange Commission (SEC)
  • Company website: https://www.priviahealth.com
  • Industry reports and research articles

Disclaimer:

This information is intended for general knowledge only and should not be considered investment advice. It is important to consult with a qualified financial advisor before making any investment decisions.

Summary

Privia Health Group Inc. is a well-positioned value-based care provider with a growing physician network and robust service offerings. The company's focus on technology and data analytics positions it for further market penetration and sustained growth.

However, Privia faces competition from established players and must navigate the complexities of the evolving healthcare landscape. The company's ability to capitalize on its strengths and overcome challenges will determine its long-term success.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Privia Health Group Inc

Exchange NASDAQ Headquaters Arlington, VA, United States
IPO Launch date 2021-04-28 CEO & Director Mr. Parth Mehrotra
Sector Healthcare Website https://www.priviahealth.com
Industry Health Information Services Full time employees 1102
Headquaters Arlington, VA, United States
CEO & Director Mr. Parth Mehrotra
Website https://www.priviahealth.com
Website https://www.priviahealth.com
Full time employees 1102

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​